Women’s Health

Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival

JAMA Oncology

In this cohort study of 1666 women with breast cancer, higher serum vitamin D levels were independently associated with better outcomes, including overall survival. Compared with women with the lowest third of 25-hydroxyvitamin D levels, those with the highest third had reduced hazards of all-cause death after full adjustment, and the associations were stronger in premenopausal women.

Related Studies

Women’s Health

Maternal 25(OH)D concentrations >40 ng/mL associated with 60% lower preterm birth risk among general obstetrical patients at an urban medical center

PLOS ONE

This study found that maternal vitamin D concentrations greater than 40 ng/mL were associated with substantial reduction in pre-term birth risk in a large, diverse population of women. Women who had a serum concentration of 25(OH)D greater or equal to 40ng/mL had a 62% lower risk of preterm births.

Women’s Health

Maternal 25(OH)D concentrations >40 ng/mL associated with 60% lower preterm birth risk among general obstetrical patients at an urban medical center

PLOS ONE

This study found that maternal vitamin D concentrations greater than 40 ng/mL were associated with substantial reduction in pre-term birth risk in a large, diverse population of women. Women who had a serum concentration of 25(OH)D greater or equal to 40ng/mL had a 62% lower risk of preterm births.

Women’s Health

Serum 25 HydroxyVitamin D Concentrations and the Risk of Hip Fractures: The Women's Health Initiative

Annals of Internal Medicine

In this study which looked at data from the Women’s Health Initiative, a 10 ng/ml decrease in vitamin D was associated with a 33% increased risk of hip fracture in multivariable models. Women with the lowest vitamin D levels had 72% increased odds of experiencing a hip fracture in comparison to women with the highest vitamin D levels.

Women’s Health

Serum 25 HydroxyVitamin D Concentrations and the Risk of Hip Fractures: The Women's Health Initiative

Annals of Internal Medicine

In this study which looked at data from the Women’s Health Initiative, a 10 ng/ml decrease in vitamin D was associated with a 33% increased risk of hip fracture in multivariable models. Women with the lowest vitamin D levels had 72% increased odds of experiencing a hip fracture in comparison to women with the highest vitamin D levels.

Women’s Health

Relationship between Low Ultraviolet B Irradiance and Higher Breast Cancer Risk in 107 Countries

The Breast Journal

This study showed that there is an increased rate of breast cancer further from the equator where there is less sunlight exposure. According to multiple regression, UVB irradiance was inversely associated with incidence rates after controlling for covariates. They also found that increasing serum 25(OH)D above 22 ng ⁄ mL was associated with incrementally lower incidence rates of breast cancer.

Women’s Health

Relationship between Low Ultraviolet B Irradiance and Higher Breast Cancer Risk in 107 Countries

The Breast Journal

This study showed that there is an increased rate of breast cancer further from the equator where there is less sunlight exposure. According to multiple regression, UVB irradiance was inversely associated with incidence rates after controlling for covariates. They also found that increasing serum 25(OH)D above 22 ng ⁄ mL was associated with incrementally lower incidence rates of breast cancer.

Get Started

Support

Partner

Be the first to get updates from Solius Labs

By signing up, I agree with the privacy policy.

Connect

Intertek logo

Solius is an FDA cleared over-the-counter (OTC) light panel intended to stimulate production of vitamin D in people 22 years and older.

Solius is clinically proven to stimulate the production of vitamin D. References to the benefits of sunlight, UVB light, and vitamin D are based upon published, peer-reviewed research. The Solius device is not intended to diagnose, treat, cure, or prevent disease, except for the indications for use described in the user manual for your applicable region. Solius does not provide specific medical advice to users. Users should seek advice from a qualified physician or healthcare provider. This website does not establish a doctor-patient relationship. For detailed product information please consult the User Manual prior to use. 

Solius® is a registered trademark of Solius Labs, Inc.
100 Ravine Lane NE, Suite 310, Bainbridge Island, WA 98110

© 2026 Solius Labs, Inc.

Get Started

Support

Partner

Be the first to get updates from Solius Labs

By signing up, I agree with the privacy policy.

Connect

Intertek logo

Solius is an FDA cleared over-the-counter (OTC) light panel intended to stimulate production of vitamin D in people 22 years and older.

Solius is clinically proven to stimulate the production of vitamin D. References to the benefits of sunlight, UVB light, and vitamin D are based upon published, peer-reviewed research. The Solius device is not intended to diagnose, treat, cure, or prevent disease, except for the indications for use described in the user manual for your applicable region. Solius does not provide specific medical advice to users. Users should seek advice from a qualified physician or healthcare provider. This website does not establish a doctor-patient relationship. For detailed product information please consult the User Manual prior to use. 

Solius® is a registered trademark of Solius Labs, Inc.
100 Ravine Lane NE, Suite 310, Bainbridge Island, WA 98110

© 2026 Solius Labs, Inc.

Get Started

Support

Partner

Be the first to get updates from Solius Labs

By signing up, I agree with the privacy policy.

Connect

Intertek logo

Solius is an FDA cleared over-the-counter (OTC) light panel intended to stimulate production of vitamin D in people 22 years and older.

Solius is clinically proven to stimulate the production of vitamin D. References to the benefits of sunlight, UVB light, and vitamin D are based upon published, peer-reviewed research. The Solius device is not intended to diagnose, treat, cure, or prevent disease, except for the indications for use described in the user manual for your applicable region. Solius does not provide specific medical advice to users. Users should seek advice from a qualified physician or healthcare provider. This website does not establish a doctor-patient relationship. For detailed product information please consult the User Manual prior to use. 

Solius® is a registered trademark of Solius Labs, Inc.
100 Ravine Lane NE, Suite 310, Bainbridge Island, WA 98110

© 2026 Solius Labs, Inc.